Anti-TOMT/ LRC51/ LRTOMT monoclonal antibody

Anti-TOMT/ LRC51/ LRTOMT antibody for FACS & in-vivo assay

Target products collectionGo to LRTOMT/LRTOMT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0772-Ab-1/ GM-Tg-hg-MP0772-Ab-2Anti-Human LRTOMT monoclonal antibodyHuman
GM-Tg-rg-MP0772-Ab-1/ GM-Tg-rg-MP0772-Ab-2Anti-Rat LRTOMT monoclonal antibodyRat
GM-Tg-mg-MP0772-Ab-1/ GM-Tg-mg-MP0772-Ab-2Anti-Mouse LRTOMT monoclonal antibodyMouse
GM-Tg-cynog-MP0772-Ab-1/ GM-Tg-cynog-MP0772-Ab-2Anti-Cynomolgus/ Rhesus macaque LRTOMT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0772-Ab-1/ GM-Tg-felg-MP0772-Ab-2Anti-Feline LRTOMT monoclonal antibodyFeline
GM-Tg-cang-MP0772-Ab-1/ GM-Tg-cang-MP0772-Ab-2Anti-Canine LRTOMT monoclonal antibodyCanine
GM-Tg-bovg-MP0772-Ab-1/ GM-Tg-bovg-MP0772-Ab-2Anti-Bovine LRTOMT monoclonal antibodyBovine
GM-Tg-equg-MP0772-Ab-1/ GM-Tg-equg-MP0772-Ab-2Anti-Equine LRTOMT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0772-Ab-1/ GM-Tg-hg-MP0772-Ab-2; GM-Tg-rg-MP0772-Ab-1/ GM-Tg-rg-MP0772-Ab-2;
GM-Tg-mg-MP0772-Ab-1/ GM-Tg-mg-MP0772-Ab-2; GM-Tg-cynog-MP0772-Ab-1/ GM-Tg-cynog-MP0772-Ab-2;
GM-Tg-felg-MP0772-Ab-1/ GM-Tg-felg-MP0772-Ab-2; GM-Tg-cang-MP0772-Ab-1/ GM-Tg-cang-MP0772-Ab-2;
GM-Tg-bovg-MP0772-Ab-1/ GM-Tg-bovg-MP0772-Ab-2; GM-Tg-equg-MP0772-Ab-1/ GM-Tg-equg-MP0772-Ab-2
Products NameAnti-LRTOMT monoclonal antibody
Formatmab
Target NameLRTOMT
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LRTOMT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TOMT/ LRC51/ LRTOMT VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001238human LRTOMT Lentivirus particle
    ORF Viral VectorpGMLP001238human LRTOMT Lentivirus plasmid


    Target information

    Target IDGM-MP0772
    Target NameLRTOMT
    Gene ID220074,718286,100066133
    Gene Symbol and SynonymsCFAP111,DFNB63,LOC100066133,LRRC51,LRRC51-TOMT,LRTOMT,TOMT
    Uniprot AccessionQ8WZ04, Q96E66,B6CZ45,B6CZ46
    Uniprot Entry NameLRC51_HUMAN,LRC51_MACMU,TOMT_MACMU
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000284922
    Target ClassificationN/A

    The target: LRTOMT, gene name: LRTOMT, also named as CFAP111, DFNB63, LRRC51. This locus represents naturally occurring readthrough transcription between the neighboring LRRC51 (leucine-rich repeat containing 51) and TOMT (transmembrane O-methyltransferase) genes on chromosome 11. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. Multiple reports implicate mutations in this gene in nonsyndromic deafness.[provided by RefSeq, Feb 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.